WHO-GMP & ISO 9001:2015 Certified • Indian Icon Award 2026 Winner
Home » Products » Sildinafil 25 mg Tablets (EVT Technology)
Active Generic Formulation Overview

Sildinafil 25 mg Tablets (EVT Technology) (TABLETS)

Sildinafil 25 mg Tablets (EVT Technology) is a DCGI-approved pharmaceutical formulation supplied in TABLETS format. Riomedica Healthcare Pvt. Ltd. provides WHO-GMP and ISO 9001:2015 certified production, contract manufacturing, bulk hospital supply, and exclusive district PCD pharma franchise monopoly rights across all Indian states.

Dosage Form: TABLETS
Category: TABLETS
Route: Oral
Quality: WHO-GMP / IP / BP / USP

Authorized Riomedica Brand Formulations (1)

RIOFORCE-25 EVT Packshot
RIOFORCE-25 EVT
Sildinafil 25 mg Tablets (EVT Technology)
₹2,200.00
View Full Product Details

Procure Sildinafil 25 mg Tablets (EVT Technology) in Bulk or Enquire for Monopoly Franchise

Whether you represent a hospital purchase department, institutional pharmacy, government tender authority, or are an entrepreneur seeking monopoly PCD pharma franchise rights, Riomedica Healthcare delivers verified pharmaceutical supplies with express batch dispatch and full COA documentation.

OFFICIAL APP Get Android App